A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/15/2002	US6465011 Formulations comprising lipid-regulating agents
10/15/2002	US6465010 Means for creating a mass having structural integrity
10/15/2002	US6465009 Water soluble polymer-based rapidly dissolving tablets and production processes thereof
10/15/2002	US6465008 For therapy of tumors
10/15/2002	US6465006 Using controlled heat and other physical means to improve dermal, mucosal, and injection administration of drugs; heating patch with iron powder for exothermic reaction
10/15/2002	US6465005 Steroid as a crystallization inhibitor during storage; inhibitor selected from an estrogen, a progestogen, an androgen and a glucocorticoid
10/15/2002	US6465004 Esterified or acylated cellulose to stabilize the concentration of the active agent in the composition and to inhibit crystal formation; pressure-sensitive adhesive carrier; cellulose acetate butyrate
10/15/2002	US6465003 Drug delivery
10/15/2002	US6465002 Liquid crystalline polymers
10/15/2002	US6465001 Treating medical conditions by polymerizing macromers to form polymeric materials
10/15/2002	US6464998 Composition for the in vivo production of therapeutic products
10/15/2002	US6464992 Topical micronutrient delivery system and uses thereof
10/15/2002	US6464990 Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields
10/15/2002	US6464989 Tea tree oil emulsion formulations
10/15/2002	US6464987 Pharmaceutical compositions capable of being gelled
10/15/2002	US6464982 Herbal immune system stimulant
10/15/2002	US6464977 Comprising mixture of particles of first composition containing electrolytes selected from sodium, calcium, magnesium, potassium chlorides and sodium acetate, particles of second composition containing sugar and above electrolytes
10/15/2002	US6464961 Polymeric delivery and release systems for oral care actives
10/15/2002	US6464959 Protective colloid stabilizer.
10/15/2002	US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/15/2002	US6464688 Osmotic pump delivery system with flexible drug compartment
10/15/2002	US6464687 Implantable drug delivery system
10/15/2002	US6463933 Bone marrow as a site for transplantation
10/15/2002	CA2337750C Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use
10/15/2002	CA2277801C Preparation of particles for inhalation
10/15/2002	CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002	CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002	CA2067274C Solvates of dirithromycin and a process for isolating form ii dirithromycin
10/15/2002	CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/15/2002	CA1341393C Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
10/12/2002	CA2343949A1 Benazepril hydrochloride tablet formulations
10/10/2002	WO2002079457A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002	WO2002079262A1 Composition for enteral nutrition comprising fibres
10/10/2002	WO2002078863A1 Generation of pharmaceutical agent particles using focused acoustic energy
10/10/2002	WO2002078830A2 Granulation method and device using focused acoustic energy
10/10/2002	WO2002078746A1 Novel chocolate composition as delivery system for nutrients and medications
10/10/2002	WO2002078728A2 Peptides for the treatment of wound contracture
10/10/2002	WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002	WO2002078716A2 Methylated promoters for intraductal treatment of breast cancer
10/10/2002	WO2002078714A1 Formulations which are resistant to gastric juice and are used to apply anti-infective compounds inhibiting the 2-c-methylerythrose-4 metabolic pathway, and the salts and esters of the same
10/10/2002	WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	WO2002078677A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002	WO2002078676A2 Enteric ketoacid salts and amino acids
10/10/2002	WO2002078675A2 Particles for inhalation having sustained release properties
10/10/2002	WO2002078674A1 A process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
10/10/2002	WO2002078673A1 Process for producing fine granulate drug
10/10/2002	WO2002078672A2 Liposomal tumor necrosis factor compositions and methods
10/10/2002	WO2002078671A1 Medical aerosol formulations
10/10/2002	WO2002078669A1 Medicinal solutions
10/10/2002	WO2002078668A2 Controlled morphologies in polymer drug for release of drugs
10/10/2002	WO2002078666A1 Metronidazole pledgets
10/10/2002	WO2002078648A2 Topical composition comprising an antifungal
10/10/2002	WO2002078624A2 Aerosol administration of interleukin-2 liposomes
10/10/2002	WO2002078616A2 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
10/10/2002	WO2002078611A2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
10/10/2002	WO2002078608A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
10/10/2002	WO2002078605A2 Premixed amiodarone parenteral solution and method for making the same
10/10/2002	WO2002078604A2 Transdermal delivery of bioactive material
10/10/2002	WO2002078602A2 Transdermal delivery of pergolide
10/10/2002	WO2002078601A2 Drug release from polymer matrices through mechanical stimulation
10/10/2002	WO2002078580A1 Condom with an erectogenic composition
10/10/2002	WO2002078578A1 Prosthetic foot with tunable performance
10/10/2002	WO2002078577A1 Prosthetic foot with tunable performance
10/10/2002	WO2002078567A2 Prosthetic foot with tunable performance
10/10/2002	WO2002078566A2 Prosthetic foot with tunable performance
10/10/2002	WO2002078459A1 Chewing gum-containing tablet
10/10/2002	WO2002078445A1 Formulations comprising entrapped active ingredients and uses thereof
10/10/2002	WO2002060410A3 Methods for sustained release local delivery of drugs for ablation of unwanted tissue
10/10/2002	WO2002058749A3 Carrier with solid fibrinogen and solid thrombin
10/10/2002	WO2002051460A3 Bioactive materials for aneurysm repair
10/10/2002	WO2002051390A3 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
10/10/2002	WO2002051386A3 Lipid microparticles by cryogenic micronization
10/10/2002	WO2002047725A3 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
10/10/2002	WO2002045769A3 A bilayer structure which encapsulates multiple containment units and uses thereof
10/10/2002	WO2002043667A3 HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
10/10/2002	WO2002041881A3 Repinotan kit
10/10/2002	WO2002039983A3 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
10/10/2002	WO2002038126A3 A process for production of particles for pharmaceutical compositions having increased bioavailability
10/10/2002	WO2002034240A3 Delayed and sustained release formulations and method of use thereof
10/10/2002	WO2002033045A3 Oligonucleotide - facilitated coalescence
10/10/2002	WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002	WO2002030472A3 Compositions for release of radiosensitizers, and methods of making and using the same
10/10/2002	WO2002030463A3 Reduced-viscosity concentrated protein formulations
10/10/2002	WO2002024159A3 Implantable drug delivery patch
10/10/2002	WO1999030691A3 Composition for the controlled release of active compounds
10/10/2002	US20020147464 Retinal treatment method
10/10/2002	US20020147346 New crystal modification of torasemide
10/10/2002	US20020147304 Non-naturally occurring lipoprotein particle
10/10/2002	US20020147296 Labeled block polymer
10/10/2002	US20020147265 Ethylene-propylene-diene terpolymer blend
10/10/2002	US20020147239 Esmolol formulation
10/10/2002	US20020147236 Controlling concentration; side effect reduction
10/10/2002	US20020147232 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
10/10/2002	US20020147216 Mucin synthesis inhibitors
10/10/2002	US20020147211 Synergistic mixture of angiotensin inhibitors, boric acid, ethylenediaminetetraacetic acid and active drug
10/10/2002	US20020147208 Anticancer agents; drug delivery to stomach
10/10/2002	US20020147202 Aqueous suspension; thermal sterilization
10/10/2002	US20020147201 Glycyrrhizin complex
10/10/2002	US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002	US20020147176 Thermoplastic and water-soluble cellulose ether esters

1 ... 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 ... 2991